Shorting the short:
Investors bet against Icahn's oil refiner after biofuel
Send a link to a friend
[August 09, 2017]
By Jarrett Renshaw and Chris Prentice
NEW YORK (Reuters) - Investors have built
up a large short position in investor Carl Icahn’s oil refining company,
CVR Energy, in the past three months, according to Reuters data, as
evidence mounts that the company’s gamble on the biofuels market is
Icahn has been one of the loudest critics of the federal biofuels
CVR, in which Icahn holds an 82 percent stake, had about 6.5 percent
short interest overall as of mid-July, up from 5.2 percent at the end of
March, according to the latest data available from Nasdaq.
That would translate to about a third of the stock not held by Icahn
being borrowed by investors betting the company’s value will decline.
Reuters was unsuccessful in efforts to reach investors in the company.
The rising short interest in CVR comes as the company’s massive gamble
on U.S. biofuels credits shows signs of going wrong.
The rising demand and limited supply for borrowed shares in CVR has
triggered a spike in borrowing fees, from normal ranges of around 2
percent to nearly 19 percent this month, said Ihor Dusaniwsky, a
managing director at financial analytics firm S3 Partners in New York.
Its own tracking figures show short interest increased to about 6.7
percent of the available shares as of last week.
Although that seems to be a relatively small amount, it is actually a
huge percentage of the shares available, given that insiders like Icahn
do not typically lend out their shares to short sellers, Dusaniwsky
Counsel for Icahn did not respond to a requests for comment late on
BIOFUEL BET SOURS
U.S. biofuels regulations require refiners either to blend biofuels into
gasoline or - in the case of companies like CVR that have no blending
facilities - to buy credits from competitors. The regulation, the
Renewable Fuel Standard, also allows companies to delay those credit
purchases by a year.
[to top of second column]
Billionaire activist-investor Carl Icahn gives an interview on FOX
Business Network's Neil Cavuto show in New York, U.S. on February
11, 2014. REUTERS/Brendan McDermid/File Photo
Last year, CVR deferred some $186 million worth of biofuels credits that it was
required to purchase under the regulation until 2017, in an apparent bet that
prices would fall within 12 months. This year, it continued to build that
position to more than $275 million, according to a Reuters review of CVR
That bet looked brilliant in March, when the credits – known as RINs – slumped
to a year-low of 33.5 cents. But it could now be a money-loser, because over the
past four months RINs prices have nearly tripled to 89 cents.
That could be fueling the increased short interest in CVR, said Paul Cheng, an
equity analyst with Barclays Capital in New York. "So far, since the beginning
of the year, you’ve been on a losing streak. At some point, you have to ask
yourself: ‘Do I want to continue betting on this?'" he said. "You are starting
to see (investors respond).”
As a special adviser to President Donald Trump, Icahn urged him in February to
alter the policy to lift the blending burden from refiners. Sources say
environmental regulators are preparing to formally reject that proposal.
Those holding short positions in CVR have watched the stock get hit hard this
year. The shares are down 27 percent in 2017, the worst performance of any U.S.
independent refiner over the period, according to a Reuters analysis.
The shares' decline has reduced Icahn’s stake in the company by $468.5 million.
A spokeswoman for CVR declined to comment.
(Reporting by Chris Prentice and Jarrett Renshaw; Editing by Dan Grebler)
[© 2017 Thomson Reuters. All rights
Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.